1Aesthetic

1Aesthetic operates as a comprehensive aesthetic medicine practice in Weehawken Township, New Jersey, combining peptide-based weight management protocols with surgical and non-surgical cosmetic procedures. The clinic has established a patient base of over 121 documented cases, maintaining a 4.6-star rating through its integration of medical weight loss with aesthetic enhancement services. Located in Hudson County, the practice serves patients throughout northern New Jersey seeking coordinated approaches to body composition and appearance optimization.

The clinic's peptide therapy program centers on two GLP-1 receptor agonists: semaglutide and tirzepatide for metabolic weight management. Semaglutide protocols typically begin at 0.25 mg weekly subcutaneous injections, escalating to maintenance doses of 1.0-2.4 mg based on individual response and tolerance. Tirzepatide treatment follows a similar titration model, starting at 2.5 mg weekly with potential escalation to 15 mg for patients requiring enhanced glucose-dependent insulinotropic polypeptide (GIP) receptor activation alongside GLP-1 agonism. These peptide interventions are coordinated with the clinic's body contouring services, allowing patients to address both metabolic factors and aesthetic concerns through synchronized treatment timelines. The practice also provides neuromodulator injections including botulinum toxin applications for facial aesthetics, laser-based skin treatments for texture and pigmentation concerns, and hair restoration protocols that complement the systemic effects of peptide therapy on cellular regeneration.

The Weehawken Township facility houses both medical consultation spaces and procedure rooms equipped for minor surgical interventions, including fat transfer procedures that relocate autologous adipose tissue for volume restoration. This surgical capability distinguishes 1Aesthetic from peptide-only clinics, enabling patients to pursue comprehensive body composition strategies that combine pharmacological weight reduction with structural enhancement. The practice's approach to injectables extends beyond basic neuromodulator applications to include dermal filler placement and other volumizing techniques, with treatment plans often spanning multiple modalities. Laser technology at the facility addresses skin laxity, vascular lesions, and unwanted hair, providing adjunctive benefits for patients whose weight loss through peptide therapy reveals underlying skin quality concerns.

Patient experiences at 1Aesthetic typically begin with consultation appointments that assess both metabolic health markers and aesthetic goals, allowing providers to construct integrated treatment sequences. Those initiating semaglutide or tirzepatide therapy receive baseline metabolic panels, body composition analysis, and education on injection technique for home administration between office visits. Follow-up appointments occur at four-week intervals during the dose escalation phase, with providers monitoring for gastrointestinal tolerance, cardiovascular parameters, and weight trajectory. Patients combining peptide therapy with procedural treatments receive coordinated scheduling to optimize healing windows and avoid interference between interventions. The clinic's documentation of 121 patient reviews reflects its volume in both injectable aesthetic services and weight management protocols, with feedback patterns indicating attention to pricing transparency and outcome expectations across treatment categories.

1Aesthetic's position in Weehawken Township provides access to the densely populated northeastern New Jersey corridor, with the clinic drawing patients from Hudson, Bergen, and Essex counties seeking alternatives to Manhattan-based practices. The facility's combination of peptide weight loss programs with surgical services creates a treatment continuum rarely available in single-location practices, allowing patients to progress from medical weight management through body contouring procedures without transferring care. This integrated model particularly benefits individuals pursuing significant body composition changes who anticipate needing both pharmacological intervention and structural revision. The practice maintains standard business hours for consultations and non-surgical treatments, with surgical procedures scheduled according to complexity and patient preparation requirements.